Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was founded on June 5, 1987 and is headquartered in Monmouth Junction, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Ayala Pharmaceuticals Inc. market cap is $25.73M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ayala Pharmaceuticals Inc. 52 week high is $0.801 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ayala Pharmaceuticals Inc. 52 week low is $0.0011 as of November 18, 2026.
Ayala Pharmaceuticals Inc. stock price today is $0.6036.
Ayala Pharmaceuticals Inc. stock price yesterday was $0.57.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Ayala Pharmaceuticals Inc. 50-day moving average is $0.21.